Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion type Assertion NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_head.
- NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion description "[The allelic frequencies of CYP3A5*1 were 25% in hepatoma patients, 33% in cervical cancer patients, 31% in breast cancer patients, 22% in oral cancer patients, 23% in thyroid cancer patients, 20% in lung cancer patients, and 27% in healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_provenance.
- NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion evidence source_evidence_literature NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_provenance.
- NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion SIO_000772 12822676 NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_provenance.
- NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion wasDerivedFrom gad-20150221 NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_provenance.
- NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_assertion wasGeneratedBy ECO_0000203 NP80326.RAiM7AHV4SYtk-rxElcPhgzdeYf6CPWiLVdEZCmOXsHjI130_provenance.